VR Logo

Nureca Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

48 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2020 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 2016

Chairman: Saurabh Goyal

Managing Director: Saurabh Goyal

Group: --

Listing: NSE: NURECA, BSE: 543264

Headquarters: Mumbai, Maharashtra

Website: www.nureca.com

Key Facts

Market cap: R 1,778.63 Cr

Revenue (TTM): R 213.45 Cr

Earnings (TTM): R 46.37 Cr

Cash: R 126.69 Cr

Total Debt: R 3.89 Cr

Promoters' ownership: 70.00%

Liquidity: High

52 Week range: R 555.60 - 2,316.60

Face value: R10.00

Shares outstanding: 1,00,00,175

Stock Performance

Time Period Nureca S&P BSE Healthcare S&P BSE Small Cap
YTD--19.3263.35
1 month8.84-2.575.56
3 months14.09-1.8312.06
1 Year--31.0499.06
3 Years--21.1328.01
5 Years--9.5717.22
10 Years--15.8315.65
As on 19-Oct-2021

Review & Analysis